Publications

Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

 147
Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

Tags:

Previous Article

Interplay between mesothelial and immune cells in the tumor microenvironment

Next Article

LSD analogue with potential for treating schizophrenia

Related Posts

Hypothalamic opsin 3 suppresses MC4R signaling and potentiates Kir7.1 to promote food consumption

Hypothalamic opsin 3 suppresses MC4R signaling and pote...

 119

Mechanosensitive calcium channels and integrins coordinate the reprogramming of colorectal cancer cells into a fetal-like state

Mechanosensitive calcium channels and integrins coordin...

 113

Endothelial metabolic control of insulin sensitivity through resident macrophages

Endothelial metabolic control of insulin sensitivity th...

 166